While complying with local directives, Cellecta is fully operational. Normal turnaround times have not been affected by COVID-19 more >

Menu
0

While complying with local directives, Cellecta is fully operational. Normal turnaround times have not been affected by COVID-19 more >

0

Your Cart is Empty

Presentations

Main menu

  • Network-anchored functional genomics identifies intra-tumoral axes of vulnerability in pancreatic cancer (View Now | 50 mins) 
  • Lineage Tracing to Dissect Functional Heterogeneity of Tumor Cells (View Now | 50 mins) 
  • CRISPR/Cas9 screens to investigate mechanisms of Cancer Drug Resistance (View Now | 50 mins)
  • Critical role of ARID1A in determining the luminal identity and therapeutic response in estrogen receptor positive (ER+) breast cancer (View Now | 25 mins)
  • NGS technologies and RNA Expression profiling for Single-Cell Genetic Analysis (View Now | 27 mins)
  • Application of DriverMap™Target RNA-Sequencing in Drug Screening (View Now | 20 mins)
  • Efficient Tools to Enable Drug Target and Biomarker Discovery: An Introduction to Cellecta Technologies (View Now | 20 mins)
  • Customer Presentation: D2G Oncology – Quantitative and Multiplexed in vivo Functional Cancer Genomics Using Barcoded CRISPR Libraries (View Now | 20 mins)
  • Assessment of Immune status and Biomarker Discovery using Blood Transcriptomics (View Now | 16 mins)
  • Loss-of-Function Genetic Screens with RNAi and CRISPR Libraries (View Now | 55 mins)
  • Molecular Snapshot with DriverMap™ Targeted Expression Profiling Assay (View Now | 25 mins) 

Oral Presentations

  • DriverMap™: Profiling the Tumor Microenvironment and Biomarkers with CancerNet™, April 2016, AACR Annual Meeting (PDF)
  • CRISPR and RNAi Loss-of-Function Genetic Screens, March 2016, MMTC (PowerPoint Slide Show)

For a list of the upcoming events we’re attending, please visit Cellecta’s Events page.